| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61D7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 |
| filingDate |
2000-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2211c5f78513238bdbd4ba07a1f6982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee9146ba34017729692a9cf429d23170
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f70747dc3e018b537c63e9afa24c75b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b9e2211d3ad32f63368a5448c1f1dd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a1abcf6cb89c61125f47bdcac6f0506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e2deba5692604f3fda199f9f22911b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24cc99a4e472a8f77c1119cf8f023c21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb66f69ac84859c880e1dc2755c84069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d936d7810d5b33282c207237381dfb7 |
| publicationDate |
2001-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2395362-A1 |
| titleOfInvention |
Osmotic beneficial agent delivery system |
| abstract |
An osmotic beneficial agent delivery system includes an implantable osmotic delivery device and a catheter for delivery of the beneficial agent from the delivery device to a delivery location. The beneficial agent delivery system includes a catheter and a docking station which are implanted in the patient with a distal end of the catheter positioned at a delivery site. The catheter and docking station are left in place while an implant containing the beneficial agent is removably connected to the catheter at the docking station and can be replaced as needed. The docking station provides a connection between a catheter and the implant allowing the implant to be replaced periodically while the catheter and the docking station remain in place. |
| priorityDate |
1999-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |